---
title: "Rovsing cuts FY 2025/26 outlook, sees revenue DKK 30-31 million and EBITDA loss DKK 4-3.5 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292024626.md"
description: "Rovsing has lowered its FY 2025/26 financial outlook, projecting revenue of DKK 30-31 million and an EBITDA loss of DKK -4 to -3.5 million. The revision stems from two backlog projects slipping due to customer delays, shifting related earnings to FY 2026/27. Additionally, positive claims from near-completion projects were not settled in the current fiscal year and are now expected to be recognized in FY 2026/27."
datetime: "2026-07-08T06:54:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292024626.md)
  - [en](https://longbridge.com/en/news/292024626.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292024626.md)
generator: "portal-rs"
---

# Rovsing cuts FY 2025/26 outlook, sees revenue DKK 30-31 million and EBITDA loss DKK 4-3.5 million

-   Rovsing cut FY 2025⁄26 revenue outlook to DKK 30-31 million from DKK 33-37 million; EBITDA now seen at DKK -4 to -3.5 million. \* Two backlog projects slipped due to customer-side delays, shifting related revenue and earnings into FY 2026⁄27. \* Positive claims tied to near-completion projects were not settled in FY 2025⁄26; recognition is now expected in FY 2026⁄27. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rovsing A/S published the original content used to generate this news brief on July 08, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

## Related News & Research

- [SenzaGen restates Q2 EBITDA to SEK -1.2 million in corrected interim report](https://longbridge.com/en/news/296509911.md)
- [APA: FY 2026 saw robust EBITDA growth, major cost savings, and a strengthened growth outlook](https://longbridge.com/en/news/296546692.md)
- [EIK: Strong H1 2026 growth with higher rental income, property gains, and raised EBITDA guidance](https://longbridge.com/en/news/296250767.md)
- [Top Eminent Healthcare swings to HK$1.4 million profit in 1H FY26; revenue rises 70.5% to HK$70.9 million](https://longbridge.com/en/news/296077290.md)
- [APA FY26 underlying EBITDA rises 8.3% to A$2.18 billion](https://longbridge.com/en/news/296410909.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**